Table 6_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). However, with the increasing number of phase 3 randomized controlled trials (RCTs) published in recent years, it is essential to re-evaluate the validity of this conclusion and to comprehensively assess the efficacy and safety across diverse patient subgroups.…”

Table 3_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). However, with the increasing number of phase 3 randomized controlled trials (RCTs) published in recent years, it is essential to re-evaluate the validity of this conclusion and to comprehensively assess the efficacy and safety across diverse patient subgroups.…”

Image 6_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). However, with the increasing number of phase 3 randomized controlled trials (RCTs) published in recent years, it is essential to re-evaluate the validity of this conclusion and to comprehensively assess the efficacy and safety across diverse patient subgroups.…”

Image 3_The benefits and risks of adding PD-1/PD-L1 inhibitors to chemotherapy for stage IIIb-IV non-small-cell lung cancer: an updated meta-analysis based on phase 3 randomized co... by Yun Xu (139234)

“…Background<p>Previous research has confirmed that integrating PD-1/PD-L1 inhibitors with chemotherapy (PC) represents a more effective strategy for treating advanced non-small-cell lung cancer (NSCLC). However, with the increasing number of phase 3 randomized controlled trials (RCTs) published in recent years, it is essential to re-evaluate the validity of this conclusion and to comprehensively assess the efficacy and safety across diverse patient subgroups.…”

Porosity Tuning in Soft-templated Mesoporous Silica: The Influence of Block Copolymer Composition and Concentration by Lysander Q. Wagner (17419267)

“…Electron tomography confirmed a spherical pore geometry and a systematic decrease in pore wall thickness upon increasing the template concentration (i.e., template-to-silica ratio) during soft templating. …”

<b>Data from: Defaunation erodes the diversity of rodent personality traits in fragmented forests</b> by Di Zeng (11891084)

Raw data for main and supplemental figures by Runhua Han (20455670)

“…<p dir="ltr">ProQ has recently emerged as a major post-transcriptional regulator in bacteria through directly binding to diverse mRNAs and small non-coding RNAs (sRNAs). However, the impact of ProQ in many pathogenic bacteria remains poorly understood. …”

Figure 6 from p300 KAT Regulates SOX10 Stability and Function in Human Melanoma by Aaron Waddell (19280272)

Gyral views of the lateral cortical surface during the wake, N2 sleep, N3 sleep and REM sleep stages. by Giridhar Kalamangalam (20968358)

Figure 4 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma by Khaled Mohamed Nassar (19810317)

Figure 2 from PELP1 Is a Novel Therapeutic Target in Hepatocellular Carcinoma by Khaled Mohamed Nassar (19810317)

Video 2_Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS.mp4 by Adam Eckardt (20573576)

“…After 3 weeks, intramuscular Bet1L siRNA injection significantly increased the number of denervated NMJs in the injected muscle. Bet1L knockdown decreased motor neuron size in the lumbar spinal cord, which innervated the siRNA-injected hindlimb. …”

Video 1_Muscle-specific Bet1L knockdown induces neuromuscular denervation, motor neuron degeneration, and motor dysfunction in a rat model of familial ALS.mp4 by Adam Eckardt (20573576)

“…After 3 weeks, intramuscular Bet1L siRNA injection significantly increased the number of denervated NMJs in the injected muscle. Bet1L knockdown decreased motor neuron size in the lumbar spinal cord, which innervated the siRNA-injected hindlimb. …”

Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain M... by James S. Wilmott (15008931)

<b>Tracking incidence classification changes across disturbances at Konza Prairie LTER</b> by Biana Qiu (22063271)

“…Ungrazed 4-year burns had more decreasing species and fewer increasing species, while grazed 4- and 20-year burns had more increasing and fewer decreasing species. …”

Growth characteristics of <i>A. baumannii</i> strains used in this study. by Techit Thavorasak (13138440)

Subjects:

Minimal inhibitory concentration of antibiotics used in this study. by Techit Thavorasak (13138440)

Subjects:

Baseline characteristics of the study population. by Hanbin Wu (14016246)

Subjects:

Directed acyclic graph for the association between maternal preconception hypoglycemia (exposure) and risks of adverse pregnancy outcomes (outcome), incorporating causal pathways a... by Hanbin Wu (14016246)

Subjects:

Protein-protein interaction network of downregulated genes involved in the peptide biosynthetic process (GO:0043043) in the <i>Acinetobacter baumannii smpB</i> mutant. by Techit Thavorasak (13138440)

Subjects: